文献速递精神分裂症与精神病性障碍

基于神经影像的脑龄预测在首发精神分裂症中的应用及早期药物治疗后脑龄的改变

Neuroimaging-based brain-age prediction of first-episode schizophrenia and the alteration of brain age after early medication.
PubMed 文献 · Br J Psychiatry · 2021-12-02

研究基于523例健康对照的弥散张量成像磁共振扫描构建脑龄预测模型,计算60例首发精神分裂症患者、60例健康对照、21例随访患者及重复数据集中40对个体的脑预测年龄差(PAD)。结果显示患者脑PAD较健康对照显著升高,早期药物治疗后脑PAD较基线显著下降(P < 0.001)。

要点

  • 首发精神分裂症患者脑预测年龄差较健康对照显著升高。
  • 早期药物治疗后患者脑预测年龄差较基线显著下降(P < 0.001)。
  • 脑预测年龄差与阳性量表评分呈负相关(r = -0.326,P = 0.014)。

核心结论

  • 首发精神分裂症患者的脑龄可能大于其实际年龄。
  • 早期药物治疗有望改善患者的脑老化。
  • 基于神经影像的脑龄预测可为理解精神分裂症提供新视角。

研究设计与样本

  • 预测模型基于523例健康对照的弥散张量成像磁共振扫描构建。
  • 在主数据集中计算60例首发精神分裂症患者、60例健康对照和21例随访患者的脑预测年龄差,并在重复数据集中计算40对个体的脑预测年龄差。
  • 比较组间脑预测年龄差并分析其与临床测量的相关性。

主要发现

  • 患者脑预测年龄差较健康对照显著升高。
  • 早期药物治疗后患者脑预测年龄差较基线显著下降(P < 0.001)。
  • 与脑预测年龄差评分相关的31/33个白质纤维束特征各向异性分数值在用药前后比较差异有统计学意义(P < 0.05,错误发现率校正)。
  • 在主数据集中,年龄差与阳性与阴性症状量表阳性评分呈负相关(r = -0.326,P = 0.014)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Neuroimaging- and machine-learning-based brain-age prediction of schizophrenia is well established. However, the diagnostic significance and the effect of early medication on first-episode schizophrenia remains unclear. AIMS: To explore whether predicted brain age can be used as a biomarker for schizophrenia diagnosis, and the relationship between clinical characteristics and brain-predicted age difference (PAD), and the effects of early medication on predicted brain age. METHOD: The predicted model was built on 523 diffusion tensor imaging magnetic resonance imaging scans from healthy controls. First, the brain-PAD of 60 patients with first-episode schizophrenia, 60 healthy controls and 21 follow-up patients from the principal data-set and 40 pairs of individuals in the replication data-set were calculated. Next, the brain-PAD between groups were compared and the correlations between brain-PAD and clinical measurements were analysed. RESULTS: The patients showed a significant increase in brain-PAD compared with healthy controls. After early medication, the brain-PAD of patients decreased significantly compared with baseline (P < 0.001). The fractional anisotropy value of 31/33 white matter tract features, which related to the brain-PAD scores, had significantly statistical differences before and after measurements (P < 0.05, false discovery rate corrected). Correlation analysis showed that the age gap was negatively associated with the positive score on the Positive and Negative Syndrome Scale in the principal data-set (r = -0.326, P = 0.014). CONCLUSIONS: The brain age of patients with first-episode schizophrenia may be older than their chronological age. Early medication holds promise for improving the patient's brain ageing. Neuroimaging-based brain-age prediction can provide novel insights into the understanding of schizophrenia.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Xi YB, Wu XS, Cui LB, et al. Neuroimaging-based brain-age prediction of first-episode schizophrenia and the alteration of brain age after early medication. Br J Psychiatry. 2021. PMID: 35049480. doi:10.1192/bjp.2021.169

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。